COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
After months of controversy, the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have given a green light to the COVID-19 booster programme in the US.
The FDA’s decision to extend the emergency use authorisation (EUA) for Pfizer’s Comirnaty vaccine comes just days after it convened a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC).
COVID-19 Pfizer/BioNTech booster approved by FDA and CDC – PMLiVE
![Het beste uit je content halen met een kloppend verhaal [10 stappen]](https://www.pharmamarketeer.nl/wp-content/uploads/2024/12/businesswoman-working-at-creative-office-2023-11-27-05-24-05-utc-1-80x60.jpg)
